Stockhead on MSN

ASX Quarterly Health Wrap: Major discovery and clinical trial progress

A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...
Le Lézard

CHCC 2026 Opens Registration, Offering a One-Stop Platform for Hospital Construction Solutions and Real-World Applications

The 27th China Hospital Construction Conference & International Hospital Build and Infrastructure Exposition (CHCC 2026), a ...
Le Lézard

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers.

Notable healthcare headlines for the week: J&J, Moderna, Bristol Myers in focus

S&P 500 healthcare weekly update: top gainers/losers and key news on J&J earnings, GSK-RAPT deal, AI lung cancer pact, and UNH rebates—Read now.

Biomarkers Market Size to Surpass USD 366.64 Billion by 2035 | Nova One Advisor

The global biomarkers market size is reached at USD 118.32 billion in 2026 and is projected to hit USD 366.64 billion by 2035 ...
Hollywood Life

‘Iron Lung’ Movie: Where to Watch Markiplier’s New Horror

Markiplier has officially made the leap from YouTube megastar to feature-film director with Iron Lung, his intense adaptation of the viral indie horror game. The self-funded project marks his debut as ...